logo
15:54 Feb 26

Sakar Healthcare Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
514.30
-6.30 (-1.21%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Sakar Healthcare Ltd. Financials

Sakar Healthcare Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
514.30
-6.30 (-1.21%)
15:54 Feb 26
Quality
image/svg+xml

79/100
High Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

71/100
Technically Bullish

Strength

12

Weakness

3

Opportunity

0

Threats

0

6.13 %

ROE %

4.21 %

ROA %

11.34

EPS

130.06

BVPS

9.85 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
94.74 128.23 133.36 153.35 177.58
Operating Expenses +
72.14 98.9 100.21 114.99 127.91
Raw Material
0 0 0 0 0
Increase Decrease in Cost
-0.91 0.93 -0.36 -1.38 -13.2
Other Manufacturing Expense
52.02 73.49 73.9 85.05 95.47
Employee Cost
13.26 15.22 16.77 19.78 31.65
Miscellaneous Expenses
7.77 9.26 9.9 11.54 13.99
Operating Profit
22.6 29.33 33.15 38.36 49.67
Other Income
1.18 2.17 4.67 3.18 1.31
Depreciation
8.06 9.67 14.99 18.05 20.88
Interest
2.48 2.9 5.95 7.59 8.53
Profit before tax and exceptio..
13.23 18.93 16.88 15.9 21.58
Exceptional Items
0 0 0 0 -0.05
PBT
13.23 18.93 16.88 15.9 21.53
Provision for Taxation
2.55 3.75 4.12 4.23 4.03
Net Profit
10.68 15.18 12.76 11.67 17.5
NET Profit after MI
10.68 15.18 12.76 11.67 17.5
EPS
6.84 8.73 6.75 5.63 7.95
Operating Profit Margin (%)
23.85 22.87 24.86 25.01 27.97
Net Profit Margin (%)
11.27 11.84 9.57 7.61 9.85

Sakar Healthcare Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 52.90 52.90 52.90 53.60 53.60 53.20
FII 13.00 13.30 13.40 13.60 13.60 13.40
Public 11.40 11.40 11.30 11.00 10.80 10.60
Others 22.70 22.40 22.40 21.80 22.00 22.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: